From Selling Pills to Selling Health Care

Click here to view on demand

As the pharmaceutical industry embarks on a dramatic shift from "selling pills" to "selling better health outcomes," drug manufacturers are increasingly focused on improving adherence to therapy and supporting patient wellness. To date, industry efforts to improve patient outcomes have been fragmented as drug marketers experiment with different adherence tactics through various channels. However, a more comprehensive approach that engages all stakeholders—patients, caregivers, physicians, pharmacists and payors—is needed to help patients achieve better health. Join us for an informative session featuring three industry experts who will examine the patient outcomes challenge and outline a new strategic model for moving forward.

Featured speakers
Dennis Urbaniak,
VP of Innovation and New Customer Channels, Sanofi-Aventis
Daniel Hawkins, Founding Member, Clarion Healthcare Consulting
Dan Rubin, President, inVentiv Patient Outcomes

James Chase,
Editor-in-Chief, Medical Marketing & Media

Sponsored by inVentiv patient outcomes
You must be a registered member of MMM to post a comment.

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.